Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation

AIMS: Therapy with phosphodiesterase‐5 inhibitors (PDE5Is) after left ventricular assist device (LVAD) implantation has been associated with lower mortality and device thrombosis but increased risk for post‐operative and gastrointestinal bleeding. We aimed to evaluate the impact of long‐term PDE5Is...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakstaite, Aiste‐Monika, Luedike, Peter, Schmack, Bastian, Pizanis, Nikolaus, Riebisch, Matthias, Weymann, Alexander, Kamler, Markus, Ruhparwar, Arjang, Rassaf, Tienush, Papathanasiou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318463/
https://www.ncbi.nlm.nih.gov/pubmed/33821578
http://dx.doi.org/10.1002/ehf2.13322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318463/
https://www.ncbi.nlm.nih.gov/pubmed/33821578
http://dx.doi.org/10.1002/ehf2.13322

Ejemplares similares